Barclays Plc stock price, TAPR

Barclays Plc stock chart:



Barclays Plc close price: 23.88

Stock price forecast:

UP TO +4.48%
Target: 24.95

Total forecasts: 81
Reached: 62 (76.54%)

Total Win: 71.99 (266.73%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90836375.90%75.863.39%516.66-39.06-7.56%36.801.67%
30231147.83%3.670.64%295.04-8.48-2.87%-4.81-0.85%
1415853.33%2.910.78%165.291.871.13%4.781.33%
78225.00%0.210.11%141.202.081.47%2.291.21%

Showing 1-10 of 536 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-04-2323.8824.950000-00-00
2017-04-2223.8824.970000-00-00
2017-04-2123.8824.990000-00-00
2017-04-2023.1225.090000-00-00
2017-04-1922.6524.50000-00-00
2017-04-1823.79123.880000-00-00
2017-04-1723.623.712017-04-17
2017-04-1623.623.72017-04-17
2017-04-1523.623.732017-04-17
2017-04-1423.623.722017-04-17

Barclays Plc latest news:


  • 04/10/2017 10:42:44

    Barclays chief Staley censured for bid to identify whistleblower

    Bank’s head faces ‘very significant’ pay cut as punishment amid FCA and BoE inquiry

  • 04/10/2017 09:26:37

    Barclays reprimands chief executive for trying to identify whistleblower

    LONDON (Reuters) - British bank Barclays has reprimanded Chief Executive Jes Staley and will cut his bonus heavily after he tried to uncover the identity of an internal company whistleblower in a case being investigated on both sides of the Atlantic.

  • 04/10/2017 01:54:07

    Regulators investigate Barclays CEO Staley over whistleblowing case

    LONDON (Reuters) - British regulators are investigating Barclays Chief Executive Jes Staley and the bank itself over the handling of a whistleblowing incident, the bank said on Monday.

  • 04/10/2017 01:05:37

    City regulators investigate Barclays boss Jes Staley

    Jes Staley's conduct over a whistleblowing letter will be investigated by two financial regulators.

  • 04/10/2017 00:43:33

    Barclays CEO Staley under investigation by regulators; bank to dock bonus

    Barclays PLC has reprimanded its chief executive, Jes Staley, and will dock his bonus after he broke rules by attempting to identify a whistleblower, the bank said Monday. U.K. regulators the Financial Conduct Authority and the Prudential Regulation Authority are investigating Barclays and Staley over their responsibilities in the incident, the bank said in a statement. In June 2016, Staley asked the Barclays's information security team to try to identify the anonymous sender of a letter that raised concerns about a senior bank employee, which Staley regarded as an unfair attack, an investigation by the bank found. "The Board believes that its response to the matter should be proportionate to its serious nature. It will therefore be issuing a formal written reprimand to Mr. Staley and has decided that a very significant compensation adjustment will be made to Mr. Staley's variable compensation award," Barclays said in its statement. It will determine the amount of the adjustment once the FCA and PRA have ended their investigations.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/07/2017 15:33:35

    Neurological drug developer Biohaven files for initial public offering

    Biohaven Pharmaceutical Holding Co. is looking to raise up to $100 million in an initial public offering, according to a Securities and Exchange Commission filing late Friday. The biotech drug developer specializes in drugs for neurological diseases with product candidate rimegepant expected to begin late-stage clinical trials for the treatment of migraines in the second half of 2017. Biohaven also expects early 2018 clinical-trial results for its drug trigriluzole for the treatment of ataxia, a condition where sufferers lose control of voluntary body movements. With no revenue, Biohaven reported a loss of $63.7 million, or $5.05 a share, in 2016. Morgan Stanley, Piper Jaffray, and Barclays are listed among the underwriters. The company plans to list on the New York Stock Exchange under the ticker "BHVN". Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/06/2017 05:40:25

    Two Barclays traders found not guilty in Libor retrial

    In a second trial, Ryan Reich and Stylianos Contogoulas are acquitted of conspiring to defraud.

  • 04/03/2017 11:59:49

    Canadian biopharma company Zymeworks files for U.S. IPO

    Canadian biopharmaceutical company Zymeworks said it has filed with the U.S. Securities and Exchange Commission for an initial public offering. The company, which develops cancer treatments, said it intends to list on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol "ZYME". Citigroup, Barclays and Wells Fargo are joint book runners with Cannacord Genuity acting as lead manager and Cormark Securities acting as co-manager. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 04/03/2017 05:11:29

    Canadian biopharma company Zymeworks files with for U.S. IPO

    Canadian biopharmaceutical company Zymeworks said it has filed with the U.S. Securities and Exchange Commission for an initial public offering. The company, which develops cancer treatments, said it intends to list on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol "ZYME". Citigroup, Barclays and Wells Fargo are joint book runners with Cannacord Genuity acting as lead manager and Cormark Securities acting as co-manager. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 03/17/2017 01:45:59

    Bob Diamond in deal to buy stockbroker Panmure Gordon

    The former Barclays boss joins forces with the Qatari royal family to take control of the broker.

  • 03/17/2017 01:34:43

    Diamond joins Qataris to launch Panmure Gordon bid

    Barclays ex-chief makes City return with move for lossmaking broker

  • 02/25/2017 09:31:38

    Barclays apologises for cash machine and debit card faults

    The bank says it is "working to fix" a problem, with phone banking also affected.

  • 02/23/2017 11:43:10

    Barclays pre-tax profits almost triple to £3.2bn 

    Surge in investment bank revenues and falling litigation costs help lender bounce back

  • 02/23/2017 02:21:44

    Barclays profits almost triple to £3.2bn

    Surge in investment banking revenues and falling litigation costs help bank bounce back

  • 02/23/2017 01:19:25

    Barclays full-year profits almost treble to £3.2bn

    "Strong progress" in restructuring helps the bank to report profits of £3.2bn.

  • 02/23/2017 01:16:19

    Barclays says it will complete its restructuring early

    Barclays Group says it will complete its restructuring six months earlier than planned as it sheds risky assets and focuses on consumer, corporate and investment banking in New York and London

  • 02/23/2017 00:28:35

    Barclays reports rise in full-year profits

    "Strong progress" in restructuring helps the bank to report profits of £3.2bn.

  • 02/16/2017 15:12:04

    BRIEF-Lennox internationalwithdrew from presenting at barclays industrial select conference

    * Withdrew from presenting at Barclays industrial select conference next week because its CFO, Joseph Reitmeier, suffers injury

  • 02/01/2017 09:45:49

    Laureate Education shares slump in market debut

    Shares of Laureate Education Inc. , a for-profit college company, slumped 8% in the company's debut on the Nasdaq Wednesday. The company priced its offering at $14 and sold 35 million shares to raise $490 million. The company gave its underwriters a 30-day option to buy up to 5.25 million additional shares at the IPO issue price. Shares were trading at $12.91 midday Wednesday. Credit Suisse, Morgan Stanley & Co and Barclays Capital were the lead underwriters on the offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/26/2017 06:58:01

    Barclays to make Dublin its EU headquarters after Brexit: source

    Barclays(BCS) is preparing to make Dublin its EU headquarters for when Britain leaves the European Union, according to a source familiar with the matter on Thursday. Global banks and insurers have begun signaling how they will put plans into action to cope with a "hard" exit from the European Union, after Prime Minister Theresa May said that Britain would leave the single market.

  • 01/24/2017 10:25:54

    Why Barclays Sees Apple as Dead Money in 2017


  • More trends:

    Barington/Hilco Acquisition Corp.BHAC | Barington/Hilco Acquisition Corp.BHACR | Barington/Hilco Acquisition Corp.BHACU | Barington/Hilco Acquisition Corp.BHACW | Barrett Business Services, Inc.BBSI | Bassett Furniture Industries, IncorporatedBSET | Bay Bancorp, Inc.BYBK | Baylake CorpBYLK | Bazaarvoice, Inc.BV | BBCN Bancorp, Inc.BBCN |